GNPX - Genprex appoints Mark S. Berger as Chief Medical Officer

Genprex (NASDAQ:GNPX) appoints Mark S. Berger to the newly-created position of Chief Medical Officer and Hemant Kumar to the newly-created position of Chief Manufacturing and Technology Officer. Drs. Berger and Kumar will report to Rodney Varner, Chief Executive Officer of Genprex. Dr. Berger is an oncologist and senior executive with 25 years of biotech and pharmaceutical company experience, most recently he served as Chief Medical Officer at Actinium Pharmaceuticals Dr. Kumar most recently served as Strategic Advisor and then Vice President, Global Head of Manufacturing, Supply Chain, and Strategy at Arcturus Therapeutics.

For further details see:

Genprex appoints Mark S. Berger as Chief Medical Officer